Searched for
CIPLA INHALER
Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...23 Apr, 2026, 01.38 PM IST- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...23 Dec, 2025, 12.09 AM IST
- Cipla shares in focus after receiving CDSCO nod to launch inhalation insulinCipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...12 Dec, 2024, 08.14 AM IST
- Cipla gets CDSCO nod to launch inhalation insulinCipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...11 Dec, 2024, 05.38 PM IST
- US unit of India's Cipla recalls six batches of bronchospasm inhalerIndian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container d...07 Jul, 2023, 10.36 AM IST
- Cipla invests in Ethris for mRNA-based inhalation therapiesThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based...29 Dec, 2022, 10.35 PM IST
- Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...18 Nov, 2021, 07.35 PM IST
- Cipla gets USFDA nod for inhalation productThe company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mc...23 Jun, 2021, 11.43 AM IST
- Cipla hits 15% upper circuit as USFDA gives final approval to Albuterol Inhalation AerosolFollowing the development, the scrip hit its 15 per cent upper circuit limit at Rs 589.95.09 Apr, 2020, 03.47 PM IST
- Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation AerosolIn a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...09 Apr, 2020, 01.14 PM IST
- Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...06 Dec, 2016, 02.00 AM IST
- GSK halves seretide price to take on CiplaAsthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...03 Aug, 2015, 05.29 AM IST
- Cipla gains as partner Sandoz gets USFDA approval for generic drugCipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.30 Jul, 2015, 04.13 PM IST
- Cipla launches combination inhalers in Germany and Sweeden; stocks touch all time high, may trigger reratingThe maiden launch increases the possibility and visibility of subsequent launches of the company’s inhalers in other countries.04 Sep, 2014, 03.32 AM IST
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...04 Jul, 2012, 05.05 AM IST
- RBS recommends a 'Buy' rating on CiplaRBS has recommended a 'Buy' rating on Cipla with a target price of 360.06 Mar, 2012, 05.23 AM IST
- Indiabulls maintains 'buy' on CiplaIndiabulls has maintained a ‘buy’ rating on Cipla after its third quarter top line increased due to a sharp rise in formulation exports and...07 Feb, 2009, 02.34 AM IST
Load More
